To better understand the specific role of bulge SCs and their niche in driving tumour initiation and differentiation, transgenic mice expressing mutant Lef1 (ΔNLef1) under control of the bulge-specific K15 promoter were analysed (Supplementary Fig. 3e)7, 9, 35. Here, KRT15 is linked to neoplasm.